Skip to main content
Back to news
Technology

Alphabet's Isomorphic Labs Raises $5 Billion for AI Drug Design

(4 days ago) · 1 source · Summarized by CryptoBipto

Isomorphic Labs, an Alphabet-owned company focused on using artificial intelligence for drug discovery, has raised $5 billion in funding. The round is one of the largest ever for an AI-focused biotech firm. The company applies deep learning techniques to design new pharmaceutical compounds.

WHY IT MATTERS

This story is about a major investment in artificial intelligence for healthcare, not about cryptocurrency directly.

Read the full analysis with a CryptoBipto membership

Members read why every story matters and the full analysis behind it.

SOURCES

  • thedefiant.io

RELATED

AIBiotechVenture CapitalNon-Crypto